Serum soluble interleukin‑2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions

Published: Sep 11, 2019
Abstract
The serum soluble interleukin 2 receptor (sIL2R) level is elevated in patients with most types of lymphoid neoplasms, and is also elevated in patients with solid tumors or reactive conditions, such as severe inflammation. To evaluate the diagnostic significance of sIL2R levels for the screening and differential diagnosis of lymphomas, data from 248 consecutive adult patients with suspected lymphoma were retrospectively analyzed in order to...
Paper Details
Title
Serum soluble interleukin‑2 receptor levels for screening for malignant lymphomas and differential diagnosis from other conditions
Published Date
Sep 11, 2019
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.